Correlation Between Regeneron Pharmaceuticals and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Tarsus Pharmaceuticals.
Diversification Opportunities for Regeneron Pharmaceuticals and Tarsus Pharmaceuticals
-0.95 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Regeneron and Tarsus is -0.95. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.79 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1,642 in Tarsus Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 3,324 from holding Tarsus Pharmaceuticals or generate 202.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regeneron Pharmaceuticals vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Regeneron Pharmaceuticals |
| Tarsus Pharmaceuticals |
Regeneron Pharmaceuticals and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regeneron Pharmaceuticals and Tarsus Pharmaceuticals
The main advantage of trading using opposite Regeneron Pharmaceuticals and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Regeneron Pharmaceuticals vs. Eliem Therapeutics | Regeneron Pharmaceuticals vs. Scpharmaceuticals | Regeneron Pharmaceuticals vs. Milestone Pharmaceuticals | Regeneron Pharmaceuticals vs. Seres Therapeutics |
| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |